Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin – Acute Coronary Syndromes Trial - O'Donoghue, M L; Bhatt, D L; Wiviott, S D (Circulation, 2011)
et al.